BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 29, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
FDA accepts Mannkind's resubmission of Afrezza NDA
July 21, 2010
CVI Pharmaceuticals identifies novel lipid-lowering agents
July 21, 2010
Aoxing confirms enrollment progress for phase III trial of TJSL capsules
July 21, 2010
KAI-4169 shows promise to treat secondary hyperparathyroidism in phase I trial
July 21, 2010
BI-10773 is safe and tolerated in healthy subjects and in type 2 diabetes
July 21, 2010
SRT-2104 improves metabolic function and glucose homeostasis in mice with DIO
July 21, 2010
Watson Pharma licenses Itero's rFSH for female infertility
July 20, 2010
Clinical data on inhaled Technosphere insulin disclosed at ADA
July 20, 2010
Merck & Co. describes novel GPR109B receptor agonists
July 20, 2010
Encouraging data disclosed on antidiabetes candidate TAK-875
July 20, 2010
Previous
1
2
…
684
685
686
687
688
689
690
691
692
…
1801
1802
Next
RSS